Cerner-Siemens Deal One Step Closer to Closing after FTC Ends Waiting Period

By Admin
Cerner, one of the largest electronic medical record companies, is one step closer to acquiring Siemens health IT unit after the Federal Trade Commissio...

Cerner, one of the largest electronic medical record companies, is one step closer to acquiring Siemens’ health IT unit after the Federal Trade Commission announced the go ahead to an early termination of the deal’s waiting period under antitrust laws.

The acquisition is still subject to other closing conditions, reported Healthcare IT News, but it remains on course for a first quarter 2015 closure. Cerner will purchase Siemens Health Services for $1.3 billion in cash.

“We’re pleased to have cleared this important regulatory hurdle and to be one step closer to integrating Siemens Health Services and its clients into the Cerner family,” said Dick Flanigan, Cerner senior vice president, in an issued news release.

According to Cerner officials, the combined revenue of the two companies will bring in $4.5 billion annually. Siemens Health Services’ employees combined with Cerner’s 14,200 associates will total nearly 20,000 associates across more than 30 countries.

Cerner officials plan to support and advance the Siemens’ Soarian platform for at least the next 10 years, according to the news site, with current implementations poised to continue.

"The concerns right now are, fundamentally, reaching out to the customer base, letting them know what's going on, and also reaching out to the staff, telling them what this all means, talking to people about what the plan is," said John Glaser, CEO of Siemens Health Services, who spoke to Healthcare IT News in August. "Until we clear certain regulatory hurdles there's only so far in certain conversations we can go."

Cerner officials anticipate the transaction will reach more than $0.15 accretive to Cerner’s non-GAAP diluted EPS in 2015, and more than $0.25 accretive in 2016. 

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma